Brief: Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification
02/06/2026 11:45
BRIEF-Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification June 2 (Reuters) - Supriya Lifescience Ltd SPRL.NS:
SUPRIYA LIFESCIENCE - LOTE FACILITY RECEIVES USFDA EIR WITH VOLUNTARY ACTION INDICATED CLASSIFICATION
Source text: ID:nBSE6NQtHf
Further company coverage: SPRL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Supriya Lifescience
See all newsBrief: Supriya Lifescience Says Court Orders Provisional Release Of 200 KG Ketamine Hydrochloride Consignment
Brief: Supriya Lifescience Limited Says June-Quarter Profit 240.4 Million Rupees
India's Supriya Lifescience on track for worst fall in a month on probe into official
Brief: Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification
India's Supriya Lifescience rises on higher quarterly profit